Indication：Hereditary angioedema in C1-esterase-inhibitor deficiency
Icatibant, sold under the brand name Firazyr, is a medication for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency. It is not effective in angioedema caused by medication from the ACE inhibitor class.
It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. It cost about US$8,000 to 9,000 per dose as of 2014.
we are cosmetic peptides supplier of icatibant from china.
ADD: Room C405, No. 488,Cuishan Rd, Xishan District, Wuxi City, Jiangsu China